Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that the Company will report its financial results for the third quarter 2014, on Thursday, November 6, 2014 prior to a conference call with the investment community, scheduled at 8:30 a.m. EST.
Help employers find you! Check out all the jobs and post your resume.
